The value of PSA measurements at 30 Gy, 50 Gy and 60 Gy for dose limitation in patients with radiotherapy for PSA increase after radical prostatectomy

Strahlentherapie und Onkologie

Volumn 178, Issue 8, 2002, Pages 422-425

  Wiegel, Thomas ^a   Bottke, Dirk ^a   Bandlow, Patrick ^a   Steiner, Ursula ^a   Hinkelbein, Wolfgang ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Prostate cancer; PSA increase following radical prostatectomy; Radiotherapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLADDER DISEASE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HISTOPATHOLOGY; HUMAN; MALE; MEASUREMENT; METASTASIS; PROSTATE CARCINOMA; PROSTATECTOMY; RADIATION DOSE; RADIATION INJURY; RECTUM DISEASE; TREATMENT PLANNING;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; TIME FACTORS;

EID: 0036331673     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-002-0917-8     Document Type: Article

References (18)

1. American Society for Therapeutic Radiology and Oncology Consensus Panel Consensus Statements on Radiation Therapy of Prostate Cancer: Guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate specific antigen levels after radical prostatectomy
2. Long term results of radiation therapy for prostate cancer recurrence following radical prostatectomy
3. Postoperative prostate antigen as a prognostic indicator in patients with margin-positive prostate cancer, undergoing adjuvant radiotherapy after radical prostatectomy
4. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: A randomized trial
5. Serum PSA evaluations during salvage radiotherapy for post-prostatectomy biochemical failures as prognosticators for treatment outcomes
6. Therapeutic irradiation for patients with an elevated post-prostatectomy prostate specific antigen level
7. Adjuvant and salvage radiotherapy after radical prostatectomy
8. Prostate specific antigen and local recurrence after radical prostatectomy
9. Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer
10. PSA kinetics after external beam radiotherapy alone or combined with an iridium brachytherapy boost to deliver 85 grays to prostatic adenocarcinoma
11. Radiotherapy for isolated serum prostate specific antigen elevation after prostatectomy for prostate cancer
12. Natural history of progression after PSA elevation following radical prostatectomy
13. Value and perspectives of proton radiation therapy for limited stage prostate cancer
14. Effect of higher radiation dose on biochemical control after radical prostatectomy for pT3N0 prostate cancer
15. Adjuvant radiation therapy does not cause urinary incontinence after radical prostatectomy: Results of a prospective randomized study
16. Positive margins after radical prostatectomy: Correlation with local recurrence and distant progression
17. The efficacy of postprostatectomy radiotherapy in patients with an isolated elevation of serum prostate-specific antigen